Literature DB >> 28861791

RT-QuIC Assays for Prion Disease Detection and Diagnostics.

Christina D Orrù1, Bradley R Groveman1, Andrew G Hughson1, Matteo Manca1, Lynne D Raymond1, Gregory J Raymond2, Katrina J Campbell1, Kelsie J Anson1, Allison Kraus1, Byron Caughey3.   

Abstract

In coping with prion diseases, it is important to have tests that are practical enough for routine applications in medicine, agriculture, wildlife biology, and research, yet sensitive enough to detect minimal amounts of infectivity. Real-time quaking-induced conversion (RT-QuIC) assays have evolved to the point where they fulfill these criteria in applications to various human and animal prion diseases. For example, RT-QuIC assays of cerebrospinal fluid and nasal brushings allow for highly sensitive (77-97%) and specific (99-100%) identification of human sCJD patients. Recent improvements have markedly enhanced sensitivity and reduced the assay time required for many samples to a matter of hours rather than days. By combining analyses of cerebrospinal fluid and nasal brushings, diagnostic sensitivities and specificities of nearly 100% can be achieved. RT-QuIC assays are based on prion-seeded amyloid fibril formation by recombinant prion protein (rPrPSen) in multiwell plates using a Thioflavin T fluorescence readout. Here we describe our current RT-QuIC methodologies as well as technical considerations in executing, troubleshooting, and adapting the assay to new strains of prions and sample types.

Entities:  

Keywords:  Amyloid; Prion; RT-QuIC; Recombinant PrPSen; TSE diagnosis

Mesh:

Substances:

Year:  2017        PMID: 28861791     DOI: 10.1007/978-1-4939-7244-9_14

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  19 in total

1.  Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development.

Authors:  Sonia M Vallabh; Chloe K Nobuhara; Franc Llorens; Inga Zerr; Piero Parchi; Sabina Capellari; Eric Kuhn; Jacob Klickstein; Jiri G Safar; Flavia C Nery; Kathryn J Swoboda; Michael D Geschwind; Henrik Zetterberg; Steven E Arnold; Eric Vallabh Minikel; Stuart L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-01       Impact factor: 11.205

2.  Domain-specific Quantification of Prion Protein in Cerebrospinal Fluid by Targeted Mass Spectrometry.

Authors:  Eric Vallabh Minikel; Eric Kuhn; Alexandra R Cocco; Sonia M Vallabh; Christina R Hartigan; Andrew G Reidenbach; Jiri G Safar; Gregory J Raymond; Michael D McCarthy; Rhonda O'Keefe; Franc Llorens; Inga Zerr; Sabina Capellari; Piero Parchi; Stuart L Schreiber; Steven A Carr
Journal:  Mol Cell Proteomics       Date:  2019-09-26       Impact factor: 5.911

3.  Multimodal small-molecule screening for human prion protein binders.

Authors:  Andrew G Reidenbach; Michael F Mesleh; Dominick Casalena; Sonia M Vallabh; Jayme L Dahlin; Alison J Leed; Alix I Chan; Dmitry L Usanov; Jenna B Yehl; Christopher T Lemke; Arthur J Campbell; Rishi N Shah; Om K Shrestha; Joshua R Sacher; Victor L Rangel; Jamie A Moroco; Murugappan Sathappa; Maria Cristina Nonato; Kong T Nguyen; S Kirk Wright; David R Liu; Florence F Wagner; Virendar K Kaushik; Douglas S Auld; Stuart L Schreiber; Eric Vallabh Minikel
Journal:  J Biol Chem       Date:  2020-07-28       Impact factor: 5.157

4.  Novel quaternary structures of the human prion protein globular domain.

Authors:  Leandro Oliveira Bortot; Victor Lopes Rangel; Francesca A Pavlovici; Kamel El Omari; Armin Wagner; Jose Brandao-Neto; Romain Talon; Frank von Delft; Andrew G Reidenbach; Sonia M Vallabh; Eric Vallabh Minikel; Stuart Schreiber; Maria Cristina Nonato
Journal:  Biochimie       Date:  2021-09-10       Impact factor: 4.079

Review 5.  The ecology of chronic wasting disease in wildlife.

Authors:  Luis E Escobar; Sandra Pritzkow; Steven N Winter; Daniel A Grear; Megan S Kirchgessner; Ernesto Dominguez-Villegas; Gustavo Machado; A Townsend Peterson; Claudio Soto
Journal:  Biol Rev Camb Philos Soc       Date:  2019-11-21

Review 6.  Are We Ready for Detecting α-Synuclein Prone to Aggregation in Patients? The Case of "Protein-Misfolding Cyclic Amplification" and "Real-Time Quaking-Induced Conversion" as Diagnostic Tools.

Authors:  Silvia Paciotti; Giovanni Bellomo; Leonardo Gatticchi; Lucilla Parnetti
Journal:  Front Neurol       Date:  2018-06-06       Impact factor: 4.003

7.  Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion disease.

Authors:  Sonia M Vallabh; Eric Vallabh Minikel; Victoria J Williams; Becky C Carlyle; Alison J McManus; Chase D Wennick; Anna Bolling; Bianca A Trombetta; David Urick; Chloe K Nobuhara; Jessica Gerber; Holly Duddy; Ingolf Lachmann; Christiane Stehmann; Steven J Collins; Kaj Blennow; Henrik Zetterberg; Steven E Arnold
Journal:  BMC Med       Date:  2020-06-18       Impact factor: 8.775

8.  Application of PMCA to screen for prion infection in a human cell line used to produce biological therapeutics.

Authors:  Adam Lyon; Charles E Mays; Frank Borriello; Glenn C Telling; Claudio Soto; Sandra Pritzkow
Journal:  Sci Rep       Date:  2019-03-19       Impact factor: 4.379

9.  Detecting Alpha Synuclein Seeding Activity in Formaldehyde-Fixed MSA Patient Tissue by PMCA.

Authors:  Katelyn Becker; Xinhe Wang; Kayla Vander Stel; Yaping Chu; Jeffrey Kordower; Jiyan Ma
Journal:  Mol Neurobiol       Date:  2018-03-27       Impact factor: 5.590

10.  Creutzfeldt-Jakob disease in pregnancy: the use of modified RT-QuIC to determine infectivity in placental tissues.

Authors:  Collin C Luk; Candace K Mathiason; Christina D Orrù; Gerard H Jansen; Allison Thiele; Byron Caughey; Valerie L Sim
Journal:  Prion       Date:  2021-12       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.